Which funds own TEVA
Teva Pharmaceutical Inds LTD in the Q2 2026 filings. At least 5 of the 91 current managers on file reported a position, worth $318m between them. It is among the largest positions of fewer than a fifth of the current managers on file. Buying and selling roughly cancelled this quarter, which is what a name looks like when the argument is still live.
- Managers holding
- 5
- at least, of 91 current
- Combined value
- $318m
- as reported
- Opened
- 0
- new this quarter
- Added to
- 2
- already held
- Trimmed or sold out
- 3
- 0 sold out entirely
Only each manager’s largest 200 positions are listed here, so a smaller holder may be missing.
Managers reporting a position
Largest first. Weight is the share of that manager’s whole reported book, which is the number worth quoting: $400m is a rounding error in one book and a defining bet in another.
| Manager | Value | Weight | Shares | Change on the quarter | Action |
|---|---|---|---|---|---|
| Glenview Capital Management LLC Long/short equity · $5.5bn book | $172m | 3.1% | 5,081,091 | -$29m-1,579,129 | Trimmed |
| Greenlight Capital Activist · $3.9bn book | $98m | 2.5% | 2,886,059 | +$10m-24,670 | Trimmed |
| Bridgewater Associates LP Macro · $24.4bn book | $45m | 0.2% | 1,326,678 | +$11m+198,272 | Added |
| ARK Investment Management LLC Long-only · $15.4bn book | $2.3m | 0.0% | 68,653 | +$300k+374 | Added |
| Farallon Capital Management LLC Long/short equity · $21.7bn book | $1.4m | 0.0% | 40,000 | -$9.3m-314,000 | Trimmed |
Ownership through time
At least 14 of the 95 managers whose filings are on file listed TEVA in Q2 2026, against 14 in Q2 2013. The same number as in Q1 2026: 2 listed it again; 2 no longer listed it among the positions read, which can mean a holding below the listed range or a filing not yet made.
Each manager’s largest 500 positions a quarter are read, so a small holding in a very large book can be missing, and a manager is counted as leaving only where its own filing shows it.
- Q2 2013: 14
- Q3 2013: 16
- Q4 2013: 17
- Q1 2014: 24
- Q2 2014: 23
- Q3 2014: 24
- Q4 2014: 25
- Q1 2015: 25
- Q2 2015: 26
- Q3 2015: 23
- Q4 2015: 25
- Q1 2016: 27
- Q2 2016: 22
- Q3 2016: 25
- Q4 2016: 19
- Q1 2017: 22
- Q2 2017: 14
- Q3 2017: 15
- Q4 2017: 14
- Q1 2018: 13
- Q2 2018: 18
- Q3 2018: 18
- Q4 2018: 19
- Q1 2019: 14
- Q2 2019: 14
- Q3 2019: 11
- Q4 2019: 9
- Q1 2020: 14
- Q2 2020: 12
- Q3 2020: 7
- Q4 2020: 5
- Q1 2021: 8
- Q2 2021: 7
- Q3 2021: 6
- Q4 2021: 4
- Q1 2022: 9
- Q2 2022: 11
- Q3 2022: 11
- Q4 2022: 11
- Q1 2023: 8
- Q2 2023: 10
- Q3 2023: 13
- Q4 2023: 10
- Q1 2024: 16
- Q2 2024: 22
- Q3 2024: 22
- Q4 2024: 18
- Q1 2025: 12
- Q2 2025: 11
- Q3 2025: 14
- Q4 2025: 16
- Q1 2026: 14
- Q2 2026: 14
- Q2 2013: $5.5bn
- Q3 2013: $5.9bn
- Q4 2013: $5.4bn
- Q1 2014: $7.7bn
- Q2 2014: $7.2bn
- Q3 2014: $7.3bn
- Q4 2014: $8.1bn
- Q1 2015: $8.7bn
- Q2 2015: $8.2bn
- Q3 2015: $8.4bn
- Q4 2015: $12.8bn
- Q1 2016: $10.3bn
- Q2 2016: $8.8bn
- Q3 2016: $7.9bn
- Q4 2016: $6.6bn
- Q1 2017: $5.9bn
- Q2 2017: $6.2bn
- Q3 2017: $3.0bn
- Q4 2017: $4.1bn
- Q1 2018: $4.8bn
- Q2 2018: $7.0bn
- Q3 2018: $6.3bn
- Q4 2018: $4.9bn
- Q1 2019: $4.7bn
- Q2 2019: $2.8bn
- Q3 2019: $2.0bn
- Q4 2019: $2.9bn
- Q1 2020: $2.0bn
- Q2 2020: $2.8bn
- Q3 2020: $2.1bn
- Q4 2020: $2.2bn
- Q1 2021: $2.6bn
- Q2 2021: $2.1bn
- Q3 2021: $1.7bn
- Q4 2021: $1.1bn
- Q1 2022: $1.4bn
- Q2 2022: $913m
- Q3 2022: $1.4bn
- Q4 2022: $1.7bn
- Q1 2023: $1.3bn
- Q2 2023: $184m
- Q3 2023: $384m
- Q4 2023: $373m
- Q1 2024: $666m
- Q2 2024: $1.8bn
- Q3 2024: $2.3bn
- Q4 2024: $3.0bn
- Q1 2025: $2.0bn
- Q2 2025: $1.8bn
- Q3 2025: $964m
- Q4 2025: $2.1bn
- Q1 2026: $2.0bn
- Q2 2026: $2.4bn
Between the quarter ends of Q1 2026 and Q2 2026. Each change in shares is valued at the Q2 2026 price, so the price’s own move is left out; a 13F shows the two quarter ends, not when in between anything was bought or sold.
Started in Q2 2026
No manager on file started a position.
Largest increases, by shares
- Capital World Investors8,833,566 to 12,536,035 shares+$125m
- Wellington Management Group LLP7,251,828 to 7,671,157 shares+$14m
- Bridgewater Associates LP1,128,406 to 1,326,678 shares+$6.7m
- Janus Henderson Group Ltd4,816,657 to 4,954,629 shares+$4.7m
- Freestone Grove Partners LP534,410 to 604,053 shares+$2.4m
Largest decreases, by shares
- Fidelity (FMR LLC)33,132,795 to 30,258,016 shares-$97m
- Glenview Capital Management LLC6,660,220 to 5,081,091 shares-$54m
- Farallon Capital Management LLC354,000 to 40,000 shares-$11m
- Greenlight Capital2,910,729 to 2,886,059 shares-$836k
- Holocene Advisors LP180,849 to 166,867 shares-$474k
Left it
No manager on file is shown leaving it.
| Manager | Value over time | First listed | Largest | Q2 2026 |
|---|---|---|---|---|
| Fidelity (FMR LLC) | Q3 2013 | $5.6bn | $1.0bn | |
| Capital World Investors | Q2 2013 | $1.0bn | $425m | |
| Wellington Management Group LLP | Q2 2013 | $2.4bn | $260m | |
| Glenview Capital Management LLC | Q2 2015 | $522m | $172m | |
| Janus Henderson Group Ltd | Q2 2013 | $385m | $168m | |
| Millennium Management LLC | Q3 2013 | $560m | $111m | |
| Greenlight Capital | Q1 2024 | $98m | $98m | |
| Bridgewater Associates LP | Q4 2015 | $45m | $45m | |
| Woodline Partners LP | Q2 2022 | $40m | $40m | |
| Freestone Grove Partners LP | Q1 2026 | $20m | $20m | |
| Holocene Advisors LP | Q3 2023 | $75m | $5.7m | |
| ARK Investment Management LLC | Q4 2017 | $5.8m | $2.3m | |
| GAMCO Investors Inc | Q1 2024 | $2.7m | $2.2m | |
| Farallon Capital Management LLC | Q3 2025 | $101m | $1.4m | |
| Capital Research Global Investors | Q2 2013 | $3.0bn | last listed Q1 2023 | |
| Viking Global Investors LP | Q1 2015 | $1.8bn | last listed Q3 2025 | |
| Invesco Ltd | Q2 2013 | $1.4bn | last listed Q3 2017 | |
| Berkshire Hathaway Inc | Q4 2017 | $1.1bn | last listed Q3 2021 | |
| Soros Fund Management LLC | Q3 2013 | $545m | last listed Q3 2018 | |
| T. Rowe Price Associates Inc | Q2 2014 | $462m | last listed Q1 2017 | |
| Neuberger Berman Group LLC | Q1 2014 | $412m | last listed Q3 2024 | |
| AllianceBernstein LP | Q4 2014 | $379m | last listed Q2 2019 | |
| D. E. Shaw & Co. | Q2 2013 | $310m | last listed Q3 2024 | |
| First Eagle Investment Management LLC | Q2 2013 | $287m | last listed Q4 2017 |
What TEVA is worth
Knowing who owns it is half the question. The other half is what it is worth against the companies it trades beside, which is the one an interviewer will follow up with.
Build the comp set around TEVA →How much of the picture this is
A Form 13F reports US-listed long equity and nothing else: no shorts, no bonds, no cash and no non-US listings. It arrives forty-five days after the quarter ends, so a manager who sold in July still shows the position in a filing published in August. This page reads the managers on file here rather than every filer in the market, and each manager’s largest positions rather than the whole table, so a small position in a very large book may not appear. Say “their last filing showed” rather than “they own”, and the distinction will do you credit.
What to do with a name the funds are buying
Knowing who owns something is the start of a pitch, not the pitch. The next questions are what it is worth and why they were buying.
Company names, tickers and logos are the trademarks of their respective owners and appear here to identify the company whose public figures are being used. L3VLUP is not affiliated with, sponsored by or endorsed by any company shown, and nothing here is a statement by or about that company. More
The holdings, every quarter, and the week between
One email a week on what moved in the market and what it means for the people interviewing into it, with the 13F changes the quarter they are filed.
One email a week, free, and you can leave at any point.